WHC is still in active development. Read this to understand our approach.
depiction of VCHHHSMPMLNVGS-UHFFFAOYSA-N.svg
psychonaut

JWH-073

Check on psychonaut

isomerdesign

JWH-073

Check on isomerdesign

pubchem

1-Butyl-3-(1-naphtho...

Check on pubchem

wiki

JWH-073

Check on wiki

Data

InChI: InChI=1S/C23H21NO/c1-2-3-15-24-16-21(19-12-6-7-14-22(19)24)23(25)20-13-8-10-17-9-4-5-11-18(17)20/h4-14,16H,2-3,15H2,1H3

Synonyms: JWH-073; JWH073,PDSP1_000254,CCG-208716,CHEBI:181123,(1-butyl-1H-indole-3-yl)-1-naphthalenyl methanone,Q423476,1-Butyl-3-(1-naphthoyl) indole,DEA No.7173,JWH-073 (methanol solution),UNII-BBX3BP2772,1-naphthalenyl(1-butyl-1h-indol-3-yl)methanone,J2.856.750B,(1-butylindol-3-yl)-naphthalen-1-ylmethanone,CS-0827,A14167,PDSP2_000253,(1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone;JWH-073,doi:10.14272/VCHHHSMPMLNVGS-UHFFFAOYSA-N.1,Naphthaten-1-yl-(1-butylindol-3-yl)methanone,(1-Butyl-1h-Indol-3-Yl)(Naphthalen-1-Yl)Methanone,C23H21NO,(1-BUTYL-1H-INDOLE-3-YL)(NAPHTHALENE-1-YL)METHANONE,JWH073,SCHEMBL11983320,987B488,BCP24000,JWH-073,DTXSID20175042,1-Butyl-3-(1-naphthoyl)-1H-indole,CHEMBL2380416,FT-0664155,(1-Butylindol-3-yl)naphthalen-1-ylmethanone,AKOS005146537,10.14272/VCHHHSMPMLNVGS-UHFFFAOYSA-N.1,NA-BIMO,N-Butyl-3-(1-naphthoyl)indole,naphthalen-1-yl-(1-butylindol-3-yl)methanone,NCGC00378993-02,Methanone, (1-butyl-1H-indol-3-yl)-1-naphthalenyl-,HSDB 7999,208987-48-8,928046-68-8,1-Naphthyl(1-butyl-1H-indole-3-yl)methanone,FT-0664154,ACT06672,1-Butyl-3-(1-naphthoyl)indole,JWH 073,BDBM85804,CTDP-32476 HCl,HY-32733,A4544,ZINC38928174,BBX3BP2772,JWH-073 solution, 100 mug/mL in acetonitrile, ampule of 1 mL, (Spice Cannabinoid), certified reference material

Market name: jwh-073


Estimated data

Solubility: -6.396 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 99.4% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.